Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 721-724, February 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carmella, S. G.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carmella, S. G.
Right arrow Articles by Hecht, S. S.

Metabolites of the Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone in Smokers' Urine1

Steven G. Carmella, Shobha Akerkar and Stephen S. Hecht

Division of Chemical Carcinogenesis, American Health Foundation, Valhalla, New York 10595

Metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent pulmonary carcinogen, have been quantified in the urine of 11 smokers. They were not detected in nonsmokers' urine. The metabolites, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronide, were detected in quantities of 0.23–1.0 and 0.57–6.5 µg/24 h, respectively. The results of this study provide the first evidence for metabolites of tobacco-specific nitrosamines in human urine.

1 This study was supported by Grant CA-29580 from the National Cancer Institute.

Received 11/17/92. Accepted 12/31/92.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
G. Chen, R. W. Dellinger, D. Sun, T. E. Spratt, and P. Lazarus
Glucuronidation of Tobacco-Specific Nitrosamines by UGT2B10
Drug Metab. Dispos., May 1, 2008; 36(5): 824 - 830.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D. K. Hatsukami
Metabolism of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone to Its Biomarker Total NNAL in Smokeless Tobacco Users
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 732 - 735.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer
Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats
Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
M. J. Stark, K. Rohde, J. E. Maher, B. A. Pizacani, C. W. Dent, R. Bard, S. G. Carmella, A. R. Benoit, N. M. Thomson, and S. S. Hecht
The Impact of Clean Indoor Air Exemptions and Preemption Policies on the Prevalence of a Tobacco-Specific Lung Carcinogen Among Nonsmoking Bar and Restaurant Workers
Am J Public Health, August 1, 2007; 97(8): 1457 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. A. Melikian, M. V. Djordjevic, S. Chen, J. Richie Jr., and S. D. Stellman
Effect of Delivered Dosage of Cigarette Smoke Toxins on the Levels of Urinary Biomarkers of Exposure
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1408 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. J. Gallagher, J. E. Muscat, A. N. Hicks, Y. Zheng, A.-M. Dyer, G. A. Chase, J. Richie, and P. Lazarus
The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 823 - 828.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
S. S. Hecht
Tobacco Carcinogen Biomarkers: Old and New
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 85 - 88.
[Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wiener, J.-L. Fang, N. Dossett, and P. Lazarus
Correlation between UDP-Glucuronosyltransferase Genotypes and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Glucuronidation Phenotype in Human Liver Microsomes
Cancer Res., February 1, 2004; 64(3): 1190 - 1196.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus
CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. E. Anderson, J. Kliris, L. Murphy, S. G. Carmella, S. Han, C. Link, R. L. Bliss, S. Puumala, S. E. Murphy, and S. S. Hecht
Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Casino Patrons
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1544 - 1546.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. Upadhyaya, C. L. Zimmerman, and S. S. Hecht
Metabolism and Pharmacokinetics of N'-Nitrosonornicotine in the Patas Monkey
Drug Metab. Dispos., October 1, 2002; 30(10): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Carcinogenesis, June 1, 2002; 23(6): 907 - 922.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z. Wu, P. Upadhyaya, S. G. Carmella, S. S. Hecht, and C. L. Zimmerman
Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution
Carcinogenesis, January 1, 2002; 23(1): 171 - 179.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. E. Anderson, S. G. Carmella, M. Ye, R. L. Bliss, C. Le, L. Murphy, and S. S. Hecht
Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke
J Natl Cancer Inst, March 7, 2001; 93(5): 378 - 381.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus
O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9
Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
P. Upadhyaya, S. G. Carmella, F.P. Guengerich, and S. S. Hecht
Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues
Carcinogenesis, June 1, 2000; 21(6): 1233 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, A. J. Dannenberg, J. Y. Park, T. R. Tephly, and P. Lazarus
Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by Rat UDP-Glucuronosyltransferase 2B1
Drug Metab. Dispos., September 1, 1999; 27(9): 1010 - 1016.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
G. B.J. Smith, A. Castonguay, P. J. Donnelly, K. R. Reid, D. Petsikas, and T. E. Massey
Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells
Carcinogenesis, September 1, 1999; 20(9): 1809 - 1818.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Upadhyaya, P. M.J. Kenney, J. B. Hochalter, M. Wang, and S. S. Hecht
Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse
Carcinogenesis, August 1, 1999; 20(8): 1577 - 1582.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. S. Hecht
Tobacco Smoke Carcinogens and Lung Cancer
J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Meger, E. Richter, W. Zwickenpflug, C. Oehlmann, M. B. Hargaden, Y. I. A-Rahim, and E. S. Vesell
Metabolism and Disposition of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Rhesus Monkeys
Drug Metab. Dispos., April 1, 1999; 27(4): 471 - 478.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
G. M. Lackmann, U. Salzberger, U. Tollner, M. Chen, S. G. Carmella, and S. S. Hecht
Metabolites of a Tobacco-Specific Carcinogen in Urine From Newborns
J Natl Cancer Inst, March 3, 1999; 91(5): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. M. Winn, P. M. Kim, and P. G. Wells
Investigation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone for In Vivo and In Vitro Murine Embryopathy and Embryonic ras Mutations
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1128 - 1135.
[Abstract] [Full Text]


Home page
NEJMHome page
S. S. Hecht, S. G. Carmella, S. E. Murphy, S. Akerkar, K. D. Brunnemann, and D. Hoffmann
A Tobacco-Specific Lung Carcinogen in the Urine of Men Exposed to Cigarette Smoke
N. Engl. J. Med., November 18, 1993; 329(21): 1543 - 1546.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.